Ex Parte DEE et al - Page 6


                Appeal No.  2002-1644                                                   Page 6                
                Application No.  08/602,498                                                                   
                According to Gardner (id., paragraph 10), the product was sold to the dairyman                
                because,                                                                                      
                      [i]f a test product is provided to the dairyman at no cost, or at a                     
                      substantially reduced cost compared to the product the dairyman is                      
                      currently using, the dairyman will have a tendency to overstate the                     
                      effectiveness of the test product in an effort to obtain a lower cost                   
                      or free test product.  If the test product is provided at a price or is                 
                      substantially near the projected retail price, an unbiased evaluation                   
                      of the product from the dairyman is usually obtained.                                   
                      As set forth in EZ Dock Inc. v. Schafer Systems Inc., 276 F. 3d 1347,                   
                1352, 61 USPQ2d 1289, 1292 (CAFC 2002), citations omitted,                                    
                      an inventor who seeks to perfect his discovery may conduct                              
                      extensive testing without losing his right to obtain a patent for his                   
                      invention – even if such testing occurs in the public eye.  The law                     
                      has long recognized the distinction between inventions put to                           
                      experimental use and products sold commercially. …                                      
                      Experimentation evidence includes “tests needed to convince [the                        
                      inventor] that the invention is capable of performing its intended                      
                      purpose in its intended environment.”                                                   
                Here as in EZ Dock, 276 F. 3d at 1352, 61 USPQ2d at 1292-93, the evidence                     
                demonstrates that the full market price was not paid for the product during                   
                testing.  Gardner declares (Gardner Declaration, paragraph 12) that he “regularly             
                monitored the efficacy of DX-206 via personal visits and phone conversations to               
                … [his] clients over at least a period of several months” and reported any                    
                problems to Babson.  As set forth in EZ Dock, 276 F.3d at 1353, 61 USPQ2d at                  
                1293 (citations omitted), “this court has often consulted evidence of monitoring to           
                discern the distinction between experimental and commercial sales.”                           
                      Based on the evidence on this record, it is our opinion, that the inventors             
                were working to detect and correct flaws in their invention during the field trials.          
                Cf. EZ Dock, 276 F.3d at 1353, 61 USPQ2d at 1293.  Accordingly, in our opinion                






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007